Dr. Saheed Olaleye Soleye, MD

Dr. Soleye practices at Piedmont Rockdale in Conyers, Georgia, part of Piedmont Healthcare.

Dr. Soleye's NPI, 1225533987, was assigned on March 26, 2018. Dr. Soleye holds Georgia license 89008.

Dr. Soleye's primary practice is Piedmont Rockdale, at 1412 Milstead Avenue, NE, Conyers, GA 30012 in Rockdale County. The practice phone is (770) 918-3000.

Dr. Soleye's primary practice is Piedmont Rockdale in Conyers, Georgia, part of Piedmont Healthcare. Dr. Soleye is also affiliated with Northside Hospital Atlanta. The medical group on file is 24 On Physicians, PC. Dmand AI also links Dr. Soleye to 1 more hospital, 6 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soleye practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Soleye's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Soleye is licensed in Georgia.

CMS data shows 810 Medicare services from Dr. Soleye across 4 procedure codes in 2024, for 285 Medicare patients. Medicare paid $52,171 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 285 Medicare patients who saw Dr. Soleye in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Soleye's median patient age at 65, with 54% women.

In 2024, Dr. Soleye wrote 93 Medicare Part D claims for 32 patients. 94% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $188 in total drug cost. In 2023, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Soleye for performance year 2024, reported through an alternative payment model (APM). Dr. Soleye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Soleye from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $44.